⚠️ The deadline to speak at our 9/20 patient listening meeting is this Friday. Share your perspective on safety considerations of approved gene therapies for rare genetic diseases and long term studies after receiving gene therapies. Request to speak here: bit.ly/3XUEQrP

Find out what's new in #biologics today. fda.gov/vaccines-blood…

Register to attend #FDACBER's 2024 Science Symposium Sept 16-18, 2024 virtually or in person. Presentation topics include emerging & re-emerging diseases, advanced manufacturing, advances in computational science, cellular, tissue, gene therapies and more! bit.ly/3YTUUdH

There’s still time to register for #CBEROTP’s upcoming #virtual town hall on 9/5! Hear FDA experts answer your questions on CMC readiness for late-stage INDs for #CellTherapy and tissue-engineered products: bit.ly/3LqCoSs

⚠️ Today is the last day to request to speak at our 9/20 meeting focusing on patient perspectives on safety considerations for approved #genetherapy treatments for rare diseases & long-term studies. We want to hear from you! Register & request to speak ➡️ bit.ly/3XUEQrP

Today, we granted emergency use authorization for an updated Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. fda.gov/news-events/pr…

Find out what's new in #biologics today. fda.gov/vaccines-blood…

Exciting news! The FDA is #AcceptingProposals on a quarterly basis for the Rare Disease Endpoint Advancement (RDEA) Pilot Program. Your proposal could help everyone in #RareDisease #DrugDevelopment! Deadline for the next review round is September 30, 2024. Bit.ly/48UBUx4

Find out what's new in #biologics today. fda.gov/vaccines-blood…

Register now for the 2024 Science Symposium, Sept 16 - 18, virtually or in person. Topics include emerging diseases, advanced manufacturing, computational science, cellular, tissue, gene therapies & more! fda.gov/news-events/fd…

Find out what's new in #biologics today. fda.gov/vaccines-blood…

Donald Kohn, MD will present "Hematopoietic Stem Cell Gene Therapy for Inherited Blood Cell Diseases" at the 2024 #FDACBER Science Symposium, September 16-18, 2024, at FDA! Register now to attend, virtually or in person. fda.gov/news-events/fd…

We are 2 weeks away from our upcoming virtual listening meeting. Register to hear from #raredisease patients, advocates, & care partners on safety considerations for approved #genetherapy treatments & post-market studies: bit.ly/3XUEQrP

Jennifer Doudna, PhD will present “How will CRISPR genome editing become a standard of care?” at the 2024 #FDACBER Science Symposium, September 16-18, 2024, at FDA! Register now to attend, virtually or in person. fda.gov/news-events/fd…

What is U.S. FDA’s role in approving new drugs and medical treatments? FDA makes sure medical treatments are safe and effective for use. We do not develop new therapies or conduct clinical trials, but rather we oversee the people who do. fda.gov/patients/clini…

Free virtual career fair on Oct. 10! Please join us from the comfort of your home office & visit virtual job booths from across HHS’ offices and agencies. You'll get information about careers and opportunities with us, as well as tips on the federal application process.

Theodore Randolph, PhD will present "Single-shot, Multi-Dose Vaccines Prepared with Atomic Layer Deposition Techniques" at the 2024 #FDACBER Science Symposium, September 16-18, 2024, at FDA! Register now to attend, virtually or in person. fda.gov/news-events/fd…

Find out what's new in #biologics today. fda.gov/vaccines-blood…